Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2008
11/05/2008EP1987036A1 Hetero-bycyclic antiviral compounds
11/05/2008EP1987035A1 Heterocyclic antiviral compounds
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1987010A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
11/05/2008EP1986652A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1781659B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1218383B1 Bicyclic imidazo-5-yl-amine derivatives
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008CN101300260A Method for synthesizing spiro quaternary ammonium systems
11/05/2008CN101300259A Tricyclic spiro derivatives as CRTH2 modulators
11/05/2008CN101300233A Azafused cyclin dependent kinase inhibitors
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN100430398C Diazabicyclic central nervous systems active agents
11/05/2008CN100430397C Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
11/05/2008CN100430396C 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor
11/04/2008US7446210 Factor Xa compounds
11/04/2008US7446209 Diazotizing a blocked 5-amino-1H-imidazole-4-carboxamide; hydrolysis; antitumor agents
11/04/2008US7446199 Compositions useful as inhibitors of protein kinases
11/04/2008US7446196 Leptomycin compounds
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
11/04/2008US7446108 Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
11/04/2008US7445845 Synthesis, spectroscopy, photophysics of multi-chromophoric ZN(II) group 8 metal complexes
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
10/2008
10/30/2008WO2008131050A1 Pyrrolotriazine kinase inhibitors
10/30/2008WO2008130951A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
10/30/2008WO2008130581A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008WO2008130314A1 Xanthine compounds having a positive allosteric gabab receptor modulator effect
10/30/2008WO2008128942A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008WO2008128921A1 Process for hcv protease inhibitor intermediate
10/30/2008WO2008085942A3 Methods for preparing arene-bis(dicarboximide)-based semiconducting materials and related intermediates for preparing same
10/30/2008WO2008074752A3 Indolylmaleimide derivatives as kinase inhibitors
10/30/2008WO2008005471A3 Novel heterobicyclic compounds
10/30/2008WO2007147104A3 Novel compounds
10/30/2008WO2007114926A3 Kinase antagonists
10/30/2008WO2007106439A3 Homotropanes with central nervous system activity
10/30/2008US20080269499 Crystalline forms and process for preparing spiro-hydantoin compounds
10/30/2008US20080269485 Fluorinated dyes and their use in electrophoretic display devices
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269230 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269184 Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
10/30/2008US20080269140 Conformationally Constrained Smac Mimetics and the Uses Thereof
10/30/2008US20080269061 Substituted thiene-3-ylsulphonylamino(thio)carbonyltriazolin(ethi)ones
10/30/2008US20080268044 Novel Process and Formulations
10/30/2008US20080267942 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality
10/30/2008US20080267906 Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity
10/30/2008US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment
10/30/2008US20080267866 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/30/2008US20080264487 Photoelectric Conversion Devices
10/30/2008CA2684659A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008CA2684633A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008CA2684086A1 Process for hcv protease inhibitor intermediate
10/30/2008CA2682301A1 Xanthine compounds having a positive allosteric gabab receptor modulator effect
10/29/2008EP1984454A1 Method of manufacturing phthalocyanine compound
10/29/2008EP1984374A1 Use of spiro ý imidazolidine-4, 3'-indole¨2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1
10/29/2008EP1984373A1 6,7-dihydrobenzimidazo[1 ,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof
10/29/2008EP1984372A1 Organic compound, anisotropic optical film and method of production thereof
10/29/2008EP1984371A1 Zopiclone resolution using l-tartaric acid
10/29/2008EP1984370A1 Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
10/29/2008EP1984369A2 Nitroimidazole compounds
10/29/2008EP1984368A2 Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b]pyrazine derivative
10/29/2008EP1984353A1 Aurora kinase modulators and method of use
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy
10/29/2008EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN101296929A Tricyclic compounds useful as oxytocin receptor agonists
10/29/2008CN101296928A Compounds and compositions as protein kinase inhibitors
10/29/2008CN101296926A Heterocyclic aspartyl protease inhibitors
10/29/2008CN101296902A Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
10/29/2008CN101296699A Pyrazolo[1,5-a]pyrimidine compounds
10/29/2008CN101293854A Novel midbody of pemetrexed, preparing method and application thereof
10/28/2008US7442804 heating under microwave irradiation (3-hydroxymethylene-4-carboxylic acid ester-2-one)pyrroline derivatives in presence of inert solvent to produce 3,6-diphenylfuro[3,4-c]pyrrole-1,4-diones (furopyrroles); intermediates in process for preparation of diketopyrrolopyrroles; high yield and purity
10/28/2008US7442795 Triazole compounds useful in therapy
10/28/2008US7442792 halogenation of pyrazolo[1,5-a][1,3,5]triazin-4-ol's, with phosphorus oxyhalides, then dehalogenation and amination to yield dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine's, used as corticotropin releasing factor (CRF) receptor antagonists; anxiolytic agents; antidepressants
10/28/2008US7442710 Substituted phenyl methanones
10/28/2008US7442700 N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1f][1,2,4]triazin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; allergies and asthma, Alzheimer's disease, rheumatoid arthritis, autoimmune diseases, bone diseases, inflammation
10/28/2008US7442694 Diazabicyclic compounds useful in the treatment of CNS and other disorders
10/28/2008US7442558 Phthalamide-lanthanide complexes for use as luminescent markers
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2380452C Imidazo-triazine derivatives as ligands for gaba receptors
10/28/2008CA2291160C Combination therapy for modulating the human sexual response
10/23/2008WO2008128072A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
10/23/2008WO2008127275A2 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof
10/23/2008WO2008127060A1 Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126105A2 Improved process for the preparation of zopiclone and it's enantiomerically enriched isomer
10/23/2008WO2008125945A2 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c
10/23/2008WO2008125833A1 Pharmaceutical compounds
10/23/2008WO2008125618A1 Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008040995A8 Indazoles for use as dpp-iv inhibitors
10/23/2008WO2007139946A3 Gpcr ligands identified by computational modeling
10/23/2008US20080262243 Reacting a vinyl sulfone compound with imide compound in presence of catalyst
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 573